» Authors » Parth S Shah

Parth S Shah

Explore the profile of Parth S Shah including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 37
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wainman L, Huang G, Green D, Tsongalis G, Tafe L, Khan W, et al.
Exp Mol Pathol . 2025 Feb; 141:104956. PMID: 39954570
Lymphoplasmacytic lymphoma (LPL) is a B-cell lymphoproliferative disorder typically involving the bone marrow with infiltration by small lymphocytes and plasma cells. Studies have identified MYD88 L265P mutation as a diagnostic...
2.
Suresh A, Wishart H, Arslan M, Lizcano R, Shah P, PonnamReddy S, et al.
Clin Lymphoma Myeloma Leuk . 2025 Jan; PMID: 39814673
Background: Immune effector cell-associated neurotoxicity syndrome (ICANS) can be a severe, life-threatening toxicity following CAR T-cell therapy. While currently evaluated by the immune effector cell-associated encephalopathy (ICE) score, not all...
3.
Kotecha U, Kim E, Shah P, Shah N, Gupta V
Clin Genet . 2025 Jan; PMID: 39754459
Arthrogryposis multiplex congenita (AMC) is a heterogeneous disorder associated with 1/3000 to 1/5000 live births. We report a consanguineous family with multiple affected members with AMC and identified a recessive...
4.
Jones V, Thompson L, Pettus J, Green D, Lefferts J, Shah P, et al.
Head Neck Pathol . 2024 Oct; 18(1):93. PMID: 39400771
Purpose: Mesenchymal neoplasms composed of vascular, smooth muscle, and adipocytic components are uncommon in the nasal cavity. While angioleiomyoma (AL) is a smooth muscle tumor in the Head & Neck...
5.
Jones V, Thompson L, Pettus J, Green D, Lefferts J, Shah P, et al.
Res Sq . 2024 Sep; PMID: 39281855
Purpose: Mesenchymal neoplasms composed of vascular, smooth muscle, and adipocytic components are uncommon in the nasal cavity. While angioleiomyoma (AL) is a smooth muscle tumor in the Head & Neck...
6.
Green J, Hackett L, Green D, Deharvengt S, Brooks G, Khan W, et al.
J Oncol Pharm Pract . 2024 Sep; :10781552241281936. PMID: 39228222
Introduction: The goal of pharmacogenetic testing is to identify genetic variants with significant implications on drug safety and efficacy. Several professional organizations and institutions have demonstrated the value of pharmacist...
7.
Shah P, Hughes E, Sukhadia S, Green D, Houde B, Tsongalis G, et al.
J Mol Diagn . 2024 Jul; 26(9):815-824. PMID: 38972591
Next-generation sequencing-based genomic testing is standard of care for tumor workflows. However, its application across different institutions continues to be challenging given the diversity of needs and resource availability among...
8.
Workman A, Green D, Hughes E, Shah P, Cloutier J, Marotti J
Int J Surg Pathol . 2024 Feb; 32(8):1525-1530. PMID: 38356303
The entity commonly referred to as chondrolipoma is a rare and enigmatic breast lesion with unclear histogenesis and a complete lack of molecular characterization. It is uncertain whether it represents...
9.
Shah P, Jacobson C
Hematol Oncol Clin North Am . 2023 Sep; 37(6):1077-1088. PMID: 37659889
The advent of chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment of several hematological malignancies. Although the initial benefit was mainly observed in aggressive leukemias and lymphomas, recent...
10.
Shah P, Jacobson C
Hematol Oncol Clin North Am . 2023 Aug; 37(6):xi-xii. PMID: 37563076
No abstract available.